PURPOSEGEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment ...

The whereabouts of a former southwest Montana teacher are unknown after he was charged with failing to register as a violent offender.